Lumos Pharma to Host Key Opinion Leader Event on LUM-201 for the Treatment of Pediatric Growth Hormone Deficiency Virtual KOL Event is scheduled for Tuesday, April 27th @ 10:30 AM ET
April 14, 2021 16:05 ET | Source: Lumos Pharma, Inc. Lumos Pharma, Inc. Austin, Texas, UNITED STATES
AUSTIN, Texas, April 14, 2021 (GLOBE NEWSWIRE) Lumos Pharma, Inc. (NASDAQ: LUMO), a clinical-stage biopharmaceutical company focused on therapeutics for rare diseases, announced today that it will host a key opinion leader (KOL) webinar on LUM-201 on Tuesday, April 27, 2021, at 10:30am ET. LUM-201 is the Company’s orally administered therapeutic candidate for the treatment of pediatric growth hormone deficiency (PGHD).
Taking precautions to avoid Lyme disease and other problems with ticks pinejournal.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pinejournal.com Daily Mail and Mail on Sunday newspapers.
POLITICO
Get the POLITICO Nightly newsletter
Email
Sign Up
By signing up you agree to receive email newsletters or updates from POLITICO and you agree to our privacy policy and terms of service. You can unsubscribe at any time and you can contact us here. This sign-up form is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Presented by
With help from Myah Ward
WAITING FOR A LEFT TURN Two years ago this week, Rep. Alexandria Ocasio-Cortez narrated a video that envisioned Democrats taking full control of Washington after 2020 and pressing ahead on a decade-long Green New Deal push with “the kind of swing-for-the-fence ambition we needed.”
Study finds correlation between COVID-19 pandemic and six unhealthy eating behaviors
A new probe into the lingering impacts of the COVID-19 pandemic revealed correlations to six unhealthy eating behaviors, according to a study by the University of Minnesota Medical School and School of Public Health. Researchers say the most concerning finding indicates a slight increase or the re-emergence of eating disorders, which kill roughly 10,200 people every year about one person every 52 minutes.
U of M Medical School s Melissa Simone, PhD, a postdoctoral research fellow in the Department of Psychiatry and Behavioral Sciences, collaborated with School of Public Health professor and head of the Division of Epidemiology and Community Health, Dianne Neumark-Sztainer, PhD, MPH, to learn from study participants in Neumark-Sztainer s Project EAT between April and May 2020.